[Severe asthma--where are we today?]

Ugeskr Laeger. 2014 Jan 13;176(3A):V05130307.
[Article in Danish]

Abstract

Severe asthma is defined by persistent symptoms and frequent exacerbations despite intensive asthma therapy. The prevalence is estimated to be 5-10% of all asthmatics. Severe asthma is responsible for a major burden of illness including low quality of life and a disproportionate use of health-care resources. The clinical assessment of severe asthma must include verification of the correct diagnosis, adherence to medication, excluding differential diagnosis and identification and treatment of aggravating co-morbidities and trigger factors.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Anti-Asthmatic Agents / administration & dosage
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma* / classification
  • Asthma* / diagnosis
  • Asthma* / drug therapy
  • Comorbidity
  • Diagnosis, Differential
  • Humans
  • Medication Adherence
  • Severity of Illness Index

Substances

  • Anti-Asthmatic Agents